Please login to the form below
Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.
This was confirmed by recent global survey data showing that pharmaceutical sales representatives are still doctors’ preferred source of pharmaceutical product information.
On 10th February at 3pm (GMT) this PMLiVE webinar, in association with Cello Health Insight, will look at how an optimal mix of face-to-face and digital initiatives can provide more meaningful and impactful marketing strategies.
Register now for the Meaningful digital initiatives need face time webinar - either to watch it live on the day or for access to a recorded version.
Featured jobs
-
Account director
-
Competitive salary and bonus scheme
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager (PR)
-
Great Benefits
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Client Services Director - Digital MedComms
-
£60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul
- Account Director, Healthcare Communications
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Publications director
-
Competitive salary and bonus scheme
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Novartis faces criticism over Zolgensma ‘health lottery’
- Novartis plans inclisiran trial in the UK
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- AZ revenues rise, but it says coronavirus could hit 2020
- Novartis pulls ahead of Merck in MET-positive lung cancer race
- Novartis plans inclisiran trial in the UK
- AZ revenues rise, but it says coronavirus could hit 2020
- Seattle Genetics wins FDA priority review for oral HER2 drug
- Eisai agrees to pull obesity drug Belviq after safety alert
- FDA begins speedy review of BMS’ CAR-T liso-cel
- It’s Teenage Kicks for Lucid Group
- 20 for 2020 – Five pharma companies to watch
No results were found
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- 20 for 2020 – Five pharma companies to watch
- As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
- The growing clinical importance of patient-reported outcomes (PROs)
- Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
- The roaring ‘20s and Generation Z
- How a new generation will shape pharma comms this decade...
Quick links
Infographics
